Thomas A. Bayer
AuthID: R-00H-BAY
1
TITLE: Chronic exposure to a synthetic cannabinoid improves cognition and increases locomotor activity in Tg4-42 Alzheimer's disease mice
AUTHORS: Ott, Frederik W.; Sichler, Marius E.; Bouter, Caroline; Enayati, Marzieh; Wiltfang, Jens; Bayer, Thomas A.; Beindorff, Nicola; Low, Maximilian J.; Bouter, Yvonne;
PUBLISHED: 2025, SOURCE: JOURNAL OF ALZHEIMERS DISEASE REPORTS, VOLUME: 9
AUTHORS: Ott, Frederik W.; Sichler, Marius E.; Bouter, Caroline; Enayati, Marzieh; Wiltfang, Jens; Bayer, Thomas A.; Beindorff, Nicola; Low, Maximilian J.; Bouter, Yvonne;
PUBLISHED: 2025, SOURCE: JOURNAL OF ALZHEIMERS DISEASE REPORTS, VOLUME: 9
INDEXED IN: 
WOS 
CrossRef
WOS CrossRef2
TITLE: N-terminal heterogeneity of parenchymal and vascular amyloid-beta deposits in Alzheimer's disease Full Text
AUTHORS: Zampar, S; Klafki, HW; Sritharen, K; Bayer, TA; Wiltfang, J; Rostagno, A; Ghiso, J; Miles, LA; Wirths, O;
PUBLISHED: 2020, SOURCE: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
AUTHORS: Zampar, S; Klafki, HW; Sritharen, K; Bayer, TA; Wiltfang, J; Rostagno, A; Ghiso, J; Miles, LA; Wirths, O;
PUBLISHED: 2020, SOURCE: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
INDEXED IN: 
Scopus WOS
Scopus WOS